Cargando…
A Preclinical Evaluation of Antimycin A as a Potential Antilung Cancer Stem Cell Agent
Drug resistance and tumor recurrence are major obstacles in treating lung cancer patients. Accumulating evidence considers lung cancer stem cells (CSCs) as the major contributor to these clinical challenges. Agents that can target lung CSCs could potentially provide a more effective treatment than t...
Autores principales: | Yeh, Chi-Tai, Su, Chun-Li, Huang, Chi-Ying F., Lin, Justin Kung-Yi, Lee, Wei-Hwa, Chang, Peter M.-H., Kuo, Yu-Lun, Liu, Yu-Wen, Wang, Liang-Shun, Wu, Chih-Hsiung, Shieh, Yi-Shing, Jan, Yi-Hua, Chuang, Yung-Jen, Hsiao, Michael, Wu, Alexander T. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693105/ https://www.ncbi.nlm.nih.gov/pubmed/23840269 http://dx.doi.org/10.1155/2013/910451 |
Ejemplares similares
-
The regulation and biosynthesis of antimycins
por: Seipke, Ryan F, et al.
Publicado: (2013) -
Coordinate Regulation of Antimycin and Candicidin Biosynthesis
por: McLean, Thomas C., et al.
Publicado: (2016) -
A phylogenetic and evolutionary analysis of antimycin biosynthesis
por: Joynt, Rebecca, et al.
Publicado: (2018) -
Yu-Ping-Feng Formula Exerts Antilung Cancer Effects by Remodeling the Tumor Microenvironment through Regulating Myeloid-Derived Suppressor Cells
por: Wang, Yuli, et al.
Publicado: (2021) -
Spectrum-Effect Relationship between UPLC Fingerprints and Antilung Cancer Effect of Si Jun Zi Tang
por: Zhou, Xiaowei, et al.
Publicado: (2019)